RPID
Rapid Micro Biosystems, Inc.
Medical Devices · Healthcare · United States
0.74
close · 2026-10-30
value
4
cheaper than peers4
quality
9
stronger fundamentals9
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 1.05× | 80 |
| price to book | 2.07× | 64 |
| earnings yield, 3 years ago | -194.3% | 9 |
| earnings yield, 1 year ago | -146.8% | 9 |
| earnings yield, 2 years ago | -165.8% | 8 |
| cash flow yield, latest year | -86.5% | 8 |
| earnings yield, latest year | -142.7% | 4 |
| cash flow yield, 2 years ago | -127.1% | 4 |
| cash flow yield, 1 year ago | -123.3% | 3 |
| cash flow yield, 3 years ago | -176.9% | 3 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 10.9% | 58 |
| debt to equity | 132.3% | 23 |
| return on equity | -141.6% | 14 |
| operating margin | -153.0% | 8 |
4 of 4 measures available
Facts
| market cap | $37M |
| free cash flow | -$21.4M |
| employees | 171 |
| first trade | 2021-07-15 |
| next earnings | 2026-08-07 |
| fundamentals updated | 2026-08-31 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | -1.05 | -1.08 | -1.22 | -1.43 | not reported |
| free cash flow | -$31.9M | -$45.5M | -$46.9M | -$65.3M | not reported |
| net income | -$47.1M | -$46.9M | -$52.5M | -$60.8M | not reported |
| revenue | $33.6M | $28.1M | $22.5M | $17.1M | not reported |
| unusual items | not reported | not reported | not reported | $0 | -$22.7M |